Mio Mejima
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
MucoRice-CTB line 19A, a new marker-free transgenic rice-based cholera vaccine produced in an LED-based hydroponic system.
Journal: Frontiers in plant science
Published: November 22, 2023
Nanogel-based nasal ghrelin vaccine prevents obesity.
Journal: Mucosal immunology
Published: June 23, 2016
Seed Metabolome Analysis of a Transgenic Rice Line Expressing Cholera Toxin B-subunit.
Journal: Scientific reports
Published: June 13, 2016
Differential analyses of major allergen proteins in wild-type rice and rice producing a fragment of anti-rotavirus antibody.
Journal: Regulatory toxicology and pharmacology : RTP
Published: September 04, 2015
Comparative whole-genome analyses of selection marker-free rice-based cholera toxin B-subunit vaccine lines and wild-type lines.
Journal: BMC genomics
Published: October 09, 2014
Nanogel-based pneumococcal surface protein A nasal vaccine induces microRNA-associated Th17 cell responses with neutralizing antibodies against Streptococcus pneumoniae in macaques.
Journal: Mucosal immunology
Published: June 01, 2014
A rice-based soluble form of a murine TNF-specific llama variable domain of heavy-chain antibody suppresses collagen-induced arthritis in mice.
Journal: Journal of biotechnology
Published: September 29, 2013
RNAi-mediated suppression of endogenous storage proteins leads to a change in localization of overexpressed cholera toxin B-subunit and the allergen protein RAG2 in rice seeds.
Journal: Plant cell reports
Published: July 13, 2013
MucoRice-cholera toxin B-subunit, a rice-based oral cholera vaccine, down-regulates the expression of α-amylase/trypsin inhibitor-like protein family as major rice allergens.
Journal: Journal of proteome research
Published: June 15, 2013
Last Updated: 09/26/2026